01—Abstract
Summary
Summary of the 8-K filed August 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Amrize Ltd (NYSE/SIX: AMRZ) reported second quarter 2026 results that showed solid top-line momentum but margin pressure from oil-price-driven cost inflation.
Revenues rose 8.6% to $3,494 milliona, with organic growth of 6.7%, driven by volume gains of $200 million, acquisitions (PB Materials) contributing $54 million, and aggregates pricing. Net income increased 14.4% to $476 million, diluted EPS rose 14.7% to $0.86, and Adjusted EBITDA grew 5.8% to $986 million, though Adjusted EBITDA margin contracted 80 basis points to 28.2%. Management raised its full-year revenue guidance to $12.5–$12.7 billion, but revised Adjusted EBITDA guidance to $3.1–$3.2 billion, reflecting the timing gap between price realization and fuel, freight, and raw material inflation.
The Building Envelope segment was the weak spot, with Adjusted EBITDA down 5.2% and margin down 350 basis points despite 9.4% revenue growth. The filing also carries an important disclosure: Amrize identified prior-period misstatements, most significantly an understatement of extended-warranty deferred revenue tied to the Duro-Last and Malarkey acquisitions ($78 millionb at December 31, 2025 and $76 million at March 31, 2026). The company concluded these were immaterial to previously issued statements but would be material if corrected in the current period, so it is revising 2025 and early-2026 comparatives in this 8-K and will reflect the revisions in future filings.
Investors should treat the restated comparatives and the reduced visibility into the prior periods as a governance and reporting-quality point to monitor in the Form 10-Q due by August 10, 2026. Capital return remained active, with $502 millionc returned to shareholders in the quarter and a $1 billion buyback launched in May 2026. Net leverage was 1.7x at June 30, 2026, and Free Cash Flow was a use of $986 million for the first half, which is typical seasonality for the business.
02—Key points
Key Highlights
- Revenue rose 8.6% to $3,494M in Q2 2026 (organic growth 6.7%), with volume growth of $200M and PB Materials acquisition contributing $54M
- Net income up 14.4% to $476M; diluted EPS up 14.7% to $0.86 and Adjusted diluted EPS up 8.6% to $0.88
- Adjusted EBITDA rose 5.8% to $986M, but margin fell 80 bps to 28.2% as oil-driven freight, diesel and raw material costs offset volume and pricing gains
- FY 2026 guidance: revenue raised to $12.5–$12.7B; Adjusted EBITDA revised to $3.1–$3.2B, reflecting cost inflation timing
- Building Envelope Adjusted EBITDA fell 5.2% to $237M with margin down 350 bps, despite 9.4% revenue growth
- Revision of prior periods: extended-warranty deferred revenue understatement ($78M at YE2025, $76M at Q1 2026) plus other immaterial items revised in this 8-K, to be reflected in the Q2 10-Q
- Shareholder returns of $502M in Q2 including a $1B buyback program launched in May 2026; net leverage 1.7x; Q2 dividend of $0.11 payable August 26, 2026
03—Questions
Frequently Asked Questions
Why did the company revise its FY 2026 Adjusted EBITDA guidance down even though it raised revenue guidance?
Management attributes the change to oil-price-driven cost inflation in freight, diesel and raw materials. Pricing and fuel surcharges are expected to offset this only partially, and there is a timing lag between price realization and cost increases that is expected to weigh on full-year earnings. The company bridges FY 2025 Adjusted EBITDA of about $3.0B to the updated $3.1–$3.2B range using volume, price, cost, ASPIRE savings (about $80M target), and insurance proceeds.
What did the prior-period revisions involve and does it affect previously reported numbers?
The most significant item is an understatement of deferred revenue for extended warranties on Duro-Last (acquired 2023) and Malarkey (acquired 2022), both in Building Envelope, at $78M as of December 31, 2025 and $76M as of March 31, 2026. The company concluded the misstatements were not material to previously issued financial statements, but it is revising the 2025 and Q1 2026 comparatives in this filing. Restated figures appear in Exhibit 99.3, and the company says future filings will reflect the revisions.
How strong is Amrize's balance sheet and liquidity position?
At June 30, 2026, gross debt was $6,004M and cash was $729M, giving net debt of $5,275M and a net leverage ratio of 1.7x. Total available liquidity was about $4.0B, the weighted average debt maturity was 6.3 years, and the company holds Baa1/BBB+ investment-grade ratings from Moody's and S&P. Free cash flow was negative $986M for the first half, which management notes is seasonal, with most cash generation expected in the second half.
What drove the weakness in the Building Envelope segment?
Segment revenue grew 9.4% on above-market volume, including large commercial roofing projects and residential share gains. However, Adjusted EBITDA fell 5.2% to $237M, and margin compressed 350 bps to 22.6%, mainly because of higher freight and raw material costs. Pricing improved sequentially through Q2, with additional increases in July and August, and management expects second-half price-cost to improve versus the first half.
What are the near-term catalysts and capital allocation priorities for investors?
Near-term items include the Q2 10-Q filing by August 10, 2026, the August 7 earnings webcast, and the $0.11 dividend with an August 18 ex-date and August 26 payment. The company launched a $1B buyback in May 2026, repurchasing $197M in Q2, and has about $241M of Q2 capex with roughly $900M planned for 2026. It also acquired Rapid Redi-Mix in July 2026, expected to be EPS accretive in 2026.
04—Continue